I'm LongbridgeAI, I can summarize articles.Recent earnings across U.S. mid-cap equities signal a divergent economic path. Defense and semiconductor equipment sectors log record backlogs, while niche agricultural and emerging tech firms flag ongoing profitability and demand headwinds.
Recent earnings and contract announcements across a broad swath of mid- and small-cap U.S. equities are sending mixed signals about the underlying strength of the economy, leaving the door open to an uneven recovery in the second half of 2026. Fed officials and market participants are increasingly open to the view that sectoral performances will remain highly bifurcated.
Powell Industries (POWL.US) reported fiscal 2026 third-quarter revenue of USD 311.7 million, up 9% from a year earlier. The company's order backlog swelled to USD 2.4 billion by the end of June. Officials point to strong demand across petrochemical and utility markets. Translation: The underlying infrastructure investment cycle remains largely intact, even as headline quarterly growth rates begin to moderate. The stock has trended lower recently despite the robust backlog.
Defense contractors and related hardware suppliers are clearly signaling sustained spending. Mercury Systems (MERC.US) logged a record USD 660 million in fourth-quarter orders, up 93.1% year-over-year, alongside a newly minted partnership with Palantir for AI-driven manufacturing. Similarly, One Stop Systems (OSS.US) reported a record quarterly order book of USD 15.1 million in its second quarter, recently expanding its reach with a USD 1.3 million U.S. Navy data storage contract. Both companies have seen their shares advance year-to-date amid this ongoing defense modernization push.
In the technology equipment space, signs of a semiconductor rebound are solidifying. Advanced Energy Industries (AEIS.US) posted second-quarter revenue of USD 574 million, a 30% increase from the prior year, buoyed by a record USD 278 million in semiconductor revenue. Aviat Networks (AVNW.US) also wrapped up its fiscal 2026 with fourth-quarter revenue of USD 120.9 million, topping consensus estimates. While officials flag improved margins, caution remains regarding global telecom capital expenditures, contributing to volatile trading in Aviat shares this year.
Emerging technology components offer a far more nuanced picture. Enovix (ENVX.US) reported second-quarter revenue of USD 9.0 million, slightly ahead of projections, as it continues to invest in scaling its silicon battery manufacturing. Wearable Devices (WLDS.US) posted marginal revenue of USD 350,000 for the first half of 2026, while expanding its net loss to USD 5.5 million. Meanwhile, STAK Inc. (STAK.US) saw first-half revenue rise 13.4% to USD 19.2 million and recently announced plans for an AI-ready distributed power subsidiary. STAK shares have exhibited significant volatility, swinging sharply in recent weeks amid low-float momentum trading.
Outside of tech, sectoral fortunes remain divided. ImmunityBio (IBRX.US) continues to build commercial momentum, reporting a record USD 50.7 million in second-quarter net product revenue—a 92% increase—following UAE approval for its cancer treatment ANKTIVA. Conversely, Bioceres Crop Solutions (BIOX.US) flagged softening demand in crop protection, reporting a 23% drop in third-quarter revenue to USD 39.4 million and a net loss of USD 10 million. The stock has underperformed the broader market this year as the company transitions its seed business to an asset-light model.
If current trends continue, officials could face a scenario where infrastructure and defense spending must carry the broader mid-cap index, while certain tech and agriculture segments await clearer catalysts. Investors will look to the upcoming fall earnings cycles for confirmation of these diverging macroeconomic paths.
This article does not constitute investment advice.